Lurasidone Inactive Metabolite 14283(CAS: 186204-32-0)

Lurasidone Inactive Metabolite 14283 (CAS: 186204-32-0) must comply with the REACH regulations for chemical substances in the European Union, ensuring that manufacturers and importers evaluate and manage the risks associated with the substance. In the United States, it must meet the FDA’s Good Manufacturing Practices (GMP) and EPA’s regulations for handling and disposal. Additionally, it should adhere to the Occupational Safety and Health Administration (OSHA) guidelines for workplace safety.

Alternatives to Lurasidone Inactive Metabolite 14283 (CAS: 186204-32-0) in synthesis include using isomers or analogs of the compound. Common alternative reagents such as similar lurasidone derivatives or related metabolites can be explored. However, thorough testing and validation are necessary to ensure the alternative meets the required safety and efficacy standards.

The market trend for Lurasidone Inactive Metabolite 14283 (CAS: 186204-32-0) is driven by ongoing research into its potential uses in drug metabolism studies and pharmacokinetic evaluations. There is a growing interest in understanding the role of inactive metabolites in drug efficacy and side effects. Additionally, the trends reflect increasing demand for safer and more efficient drug development processes.

Waste containing Lurasidone Inactive Metabolite 14283 (CAS: 186204-32-0) should be handled by collecting it in appropriate containers and disposing of it through professional waste disposal services. Incineration is a common method, but environmental protection precautions must be taken to minimize pollution. Alternatively, chemical neutralization or other safe disposal methods should be used, and all disposal activities should comply with local and international regulations, such as the Resource Conservation and Recovery Act (RCRA) in the U.S.